Pregnancy Clinical Trial
— WATEOfficial title:
WATE Study - Gestational Weight Gain and the Electronic Medical Record
NCT number | NCT01987141 |
Other study ID # | 205512 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | October 29, 2013 |
Last updated | September 11, 2014 |
Start date | October 2013 |
Less than one third of pregnant women actually achieve the Institute of Medicine's (IOM)
recommended weight gain. To date, there are no randomized controlled trials studying the use
of the electronic medical record to alert providers to initiate the counseling of patients
on the IOM gestational weight gain recommendations.
In the investigator's planned study intervention, using the EPIC EMR system, an electronic
alert (Best Practice Advisory) will appear for providers at each prenatal care visit. This
alert will remind providers to counsel patients on the recommendations for gestational
weight gain. The control group will receive standard prenatal care, without electronic
alerts generated regarding BMI and gestational weight gain.
The investigators hypothesize that a higher percentage of patients who receive the
intervention will meet the IOM guidelines for weight gain.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | |
Est. primary completion date | October 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Pregnant with a single intrauterine gestation - Present for new OB visit up to 13 weeks and 6 days gestation Exclusion Criteria: - They have a multiple gestation pregnancy - They are under the age of 18 - They do not speak English |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Loyola University Medical Center | Maywood | Illinois |
Lead Sponsor | Collaborator |
---|---|
Loyola University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight gain | Primary outcome will be measured as the percent of patients who achieve their recommended weight gain goal in pregnancy (IOM guidelines) | At delivery, average of 40 weeks from enrollment | No |
Secondary | Patient perception | Survey to patients at the end of pregnancy regarding how patients perceive and are influenced by EMR notifications and counseling | At end of pregnancy, average of 40 weeks from enrollment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |